Table 2.
Name | Sequence |
---|---|
LC3 | |
Forward | 5′-TACGAGCAGGAGAAAGACGAGG-3′ |
Reverse | 5′-GGCAGAGTARGGTGGGTTGGTG-3′ |
TLR3 | |
Forward | 5′-CCTGGTTTGTTAATTGGATTAACGA-3′ |
Reverse | 5′-TGA GGTGGAGTGTTGCAAAGG-3′ |
TRIF | |
Forward | 5′-GGCCCATCACTTCCTAGCG-3′ |
Reverse | 5′-GAGAGATCCTGGCCTCAGTTT-3′ |
Caspase 3 | |
Forward | 5′-AGAACTGGACTGTGGCATTGAG-3′ |
Reverse | 5′-GCTTGTCGGCATACTGTTTCAG-3′ |
Caspase 8 | |
Forward | 5′-CATCCAGTCACTTTGCCAGA-3′ |
Reverse | 5′-GCATCTGTTTCCCCATGTTT-3′ |
Caspase 9 | |
Forward | 5′-GGCTGTCTACGGCACAGATGGA-3′ |
Reverse | 5′-CTGGCTCGGGGTTACTGCCAG-3′ |
GAPDH | |
Forward | 5′-GAAGGTGAAGGTCGGAGTC-3′ |
Reverse | 5′-GAAGATGGTGATGGGATTC-3′ |
LC3, microtubule-associated protein light chain 3; TLR3, Toll-like receptor 3; TRIF, Toll–interleukin-1 receptor domain-containing adaptor inducing interferon β; GAPDH, glyceraldehyde-3-phosphate dehydrogenase.